CytoSorbents makes blood purification cartridges that remove toxins and inflammatory substances from blood for hospitals and veterinary clinics. CTSO reports earnings on Thu, Nov 12, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 21 | WBB Securities | Initiated | Buy |
Seasonality
How CTSO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in CTSO in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CTSO is in one of them and how their past CTSO trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered CTSO in an article yet. Here's the latest on the wider market.
About Cytosorbents
CytoSorbents is a medical device company based in Princeton, New Jersey. It makes blood purification cartridges filled with porous polymer beads that remove harmful substances from blood. Its main product, CytoSorb, is sold to hospitals for use in intensive care and cardiac surgery, where it connects to blood pumps already in use. The company also sells products for emergency care in animals and is seeking U.S. approval for a device that removes certain blood thinners during heart surgery.
- Headquarters
- Princeton, NJ